NCT04476121 is a NA clinical trial of PRF application in Alveolar Osteitis, sponsored by Medical University of Lodz.

Who is sponsoring NCT04476121?

NCT04476121 is sponsored by Medical University of Lodz.

What drugs are being tested in NCT04476121?

Interventions in NCT04476121: PRF application, Nipas application.

What condition does NCT04476121 study?

NCT04476121 studies Alveolar Osteitis.

Is NCT04476121 still recruiting?

NCT04476121 is currently status unknown. Last updated 26 April 2021.

Last reviewed 2021-04-26 · How we verify

NCT04476121

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of PRF in Treatment of Dry Socket.

Status unknown NA Last updated 26 April 2021

What this trial tests

NA trial testing PRF application in Alveolar Osteitis in 30 participants. Status unknown.

Timeline

1 January 2019

Primary endpoint
1 July 2021

1 July 2021

Quick facts

Lead sponsor	Medical University of Lodz
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 January 2019
Primary completion	1 July 2021
Estimated completion	1 July 2021
Sites	1 location across Poland

Drugs / interventions tested

PRF application
Nipas application — full drug profile →

Conditions studied

Alveolar Osteitis — all drugs for Alveolar Osteitis →

Sponsor

Medical University of Lodz

Who can join

Adults 18 to 70, any sex, with Alveolar Osteitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the influence of PRF application in case of alveolar osteitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alveolar Osteitis

Currently open trials in the same condition.

NCT06435832 — Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence · NA · active not recruiting

Other Medical University of Lodz trials

Trials by the same sponsor.

NCT07391969 — Evaluation of SaCo VLMA for General Anesthesia for Laparoscopic Procedures · NA · not yet recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting
NCT06850597 — Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's D · Phase 2 · recruiting
NCT06917300 — Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergoing Spine Surgery · NA · recruiting
NCT06391216 — The Effect of Probiotic Supplementation on Mental Health in Healthy Volunteers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04476121 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Lodz
Last refreshed: 26 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04476121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing